PCN125 AN ECONOMICAL, RANDOMIZED, MULTICENTER PHASE III TRIAL OF SECOND LINE TREATMENT FOR NON SMALL CELL LUNG CANCER (NSCLC) COMPARING DOCETAXEL VERSUS PEMETREXED- GFPC (GROUPE FRANROLOGIE) 05-06 STUDY

Oct 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74376-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)74376-X/fulltext
Section Title :
Section Order : 303
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74376-X&doi=10.1016/S1098-3015(10)74376-X
HEOR Topics :
Tags :
Regions :